Cargando…
Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients
BACKGROUND: Despite significant benefits of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with EGFR-mutated NSCLC, access remains limited in Thailand and elsewhere. METHODS: Retrospective analysis of patients with locally advanced/recurrent NSCLC and kno...
Autores principales: | Khiewngam, Khantong, Oranratnachai, Songporn, Kamprerasart, Kaettipong, Kunakorntham, Patratorn, Sanvarinda, Pimtip, Trachu, Narumol, Pimsa, Pongput, Wiwitkeyoonwong, Jirapath, Thamrongjirapat, Thanaporn, Dejthevaporn, Thitiya, Sirachainan, Ekaphop, Reungwetwattana, Thanyanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989298/ https://www.ncbi.nlm.nih.gov/pubmed/36895484 http://dx.doi.org/10.3389/fonc.2023.1047644 |
Ejemplares similares
-
Role of BIM Deletion Polymorphism and BIM Expression as Predictive Biomarkers to Maximize the Benefit of EGFR-TKI Treatment in EGFR-Positive NSCLC
por: Incharoen, Pimpin, et al.
Publicado: (2019) -
CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients
por: Majam, Teerapat, et al.
Publicado: (2023) -
ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
por: Incharoen, Pimpin, et al.
Publicado: (2016) -
CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients
por: Sirachainan, Ekaphop, et al.
Publicado: (2012) -
Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
por: Saifon, Woraseth, et al.
Publicado: (2022)